The main task of the Nomination Committee is to submit proposals for Chairman of the Board and other members of the Board, remuneration for Board work, the election and remuneration of auditors. The Nomination Committee shall be composed of the Chairman of the Board and members appointed by the three largest shareholders in the company based on ownership of the Company as per the end of
Accordingly, the following committee members have been appointed:
- Marianne Dicander Alexandersson, Chairman of the Board
David Sundin , representingCorespring New Technology AB (former Midroc New Technology)Candice Jung , representingPharmaResearch Co. Ltd Jari Pulkkinen , representing a co-registered group of shareholders, with an ownership equivalent to 8.1% of the company
The Nomination Committee’s proposals will be presented in the Notice to the AGM 2023 and on the company web site, http://www.promorepharma.com. Shareholders desiring to submit comments or proposals to the nomination committee can send them via email to info@promorepharma.com.
© Modular Finance, source